Sutro Biopharma Inc (STRO) USD0.001

Sell:$23.11Buy:$26.34Price decreased$4.50 (14.68%)

NASDAQ:Price increased0.19%
Market closed |
Prices delayed by at least 15 minutes
Sell:$23.11
Buy:$26.34
Change:Price decreased$4.50 (14.68%)
Market closed |
Prices delayed by at least 15 minutes
Sell:$23.11
Buy:$26.34
Change:Price decreased$4.50 (14.68%)
Market closed |
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
4 March 2026
Jane ChungCEO
Sell
Tax related
282$21.31$6,009.4221,285
4 March 2026
David PaulingChief Level Officer
Sell
Tax related
277$21.31$5,902.879,748
2 March 2026
Jane ChungCEO
Sell
Tax related
2,779$20.55$57,108.4520,779
2 March 2026
Hans-Peter GerberChief Level Officer
Sell
Tax related
1,170$20.55$24,043.509,518
2 March 2026
David PaulingChief Level Officer
Sell
Tax related
970$20.55$19,933.509,350
1 March 2026
Jane ChungCEO
Sell
Tax related
1,271$20.47$26,017.3715,808
1 March 2026
David PaulingChief Level Officer
Sell
Tax related
551$20.47$11,278.977,964
1 March 2026
Hans-Peter GerberChief Level Officer
Sell
Tax related
463$20.47$9,477.617,845
12 December 2025
Jane ChungCEO
Sell
Tax related
894$8.02$7,165.4113,891
15 October 2025
Jane ChungCEO
Buy
Regular purchase transaction
12,500$0.80$10,011.25122,850

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
2 March 2026
Jane ChungCEO
Sell
Tax related
2,779$20.55$57,108.4520,779
15 October 2025
Connie L. MatsuiChairman of the Board
Buy
Regular purchase transaction
50,000$0.80$39,950.0050,000
1 March 2026
Jane ChungCEO
Sell
Tax related
1,271$20.47$26,017.3715,808
2 March 2026
Hans-Peter GerberChief Level Officer
Sell
Tax related
1,170$20.55$24,043.509,518
2 March 2026
David PaulingChief Level Officer
Sell
Tax related
970$20.55$19,933.509,350

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.